MXPA04010674A - Moleculas de reconocimiento en superficie de celula que contienen dominio de inmunoglobulina. - Google Patents
Moleculas de reconocimiento en superficie de celula que contienen dominio de inmunoglobulina.Info
- Publication number
- MXPA04010674A MXPA04010674A MXPA04010674A MXPA04010674A MXPA04010674A MX PA04010674 A MXPA04010674 A MX PA04010674A MX PA04010674 A MXPA04010674 A MX PA04010674A MX PA04010674 A MXPA04010674 A MX PA04010674A MX PA04010674 A MXPA04010674 A MX PA04010674A
- Authority
- MX
- Mexico
- Prior art keywords
- seq
- polypeptide
- nucleic acid
- disease
- acid molecule
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Plant Pathology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0209884.6A GB0209884D0 (en) | 2002-04-30 | 2002-04-30 | Proteins |
| PCT/GB2003/001851 WO2003093316A2 (en) | 2002-04-30 | 2003-04-30 | Immunoglobulin-domain containing cell surface recognition molecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04010674A true MXPA04010674A (es) | 2005-02-17 |
Family
ID=9935806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04010674A MXPA04010674A (es) | 2002-04-30 | 2003-04-30 | Moleculas de reconocimiento en superficie de celula que contienen dominio de inmunoglobulina. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7622555B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1499640A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006502702A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20050008699A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1665840A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003229961B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0309638A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2483038A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA007985B1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0209884D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL164777A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04010674A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20044628L (cg-RX-API-DMAC7.html) |
| RS (1) | RS92704A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003093316A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200408453B (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0326393D0 (en) * | 2003-11-12 | 2003-12-17 | Ares Trading Sa | Cytokine antagonist molecules |
| US20080193414A1 (en) * | 2005-05-06 | 2008-08-14 | Amanda Proudfoot | Use of an Immunoglobulin Domain-Containing Cell Surface Recognition Molecule For Treating Diseases |
| CN100402551C (zh) * | 2006-04-14 | 2008-07-16 | 中国科学院长春应用化学研究所 | β2-微球蛋白的抗原表位及应用 |
| JP2010500978A (ja) | 2006-08-17 | 2010-01-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ウイルスポリメラーゼインヒビター |
| US8178101B2 (en) | 2007-05-21 | 2012-05-15 | Alderbio Holdings Inc. | Use of anti-IL-6 antibodies having specific binding properties to treat cachexia |
| KR101829776B1 (ko) | 2007-05-21 | 2018-02-19 | 앨더바이오 홀딩스 엘엘씨 | Ｉｌ-６에 대한 항체 및 이의 용도 |
| US8252286B2 (en) | 2007-05-21 | 2012-08-28 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat thrombosis |
| US7906117B2 (en) | 2007-05-21 | 2011-03-15 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever |
| US8062864B2 (en) * | 2007-05-21 | 2011-11-22 | Alderbio Holdings Llc | Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies |
| US8404235B2 (en) | 2007-05-21 | 2013-03-26 | Alderbio Holdings Llc | Antagonists of IL-6 to raise albumin and/or lower CRP |
| US9701747B2 (en) | 2007-05-21 | 2017-07-11 | Alderbio Holdings Llc | Method of improving patient survivability and quality of life by anti-IL-6 antibody administration |
| US8992920B2 (en) | 2008-11-25 | 2015-03-31 | Alderbio Holdings Llc | Anti-IL-6 antibodies for the treatment of arthritis |
| US9452227B2 (en) | 2008-11-25 | 2016-09-27 | Alderbio Holdings Llc | Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments |
| US9212223B2 (en) | 2008-11-25 | 2015-12-15 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat thrombosis |
| US8323649B2 (en) | 2008-11-25 | 2012-12-04 | Alderbio Holdings Llc | Antibodies to IL-6 and use thereof |
| US8420089B2 (en) | 2008-11-25 | 2013-04-16 | Alderbio Holdings Llc | Antagonists of IL-6 to raise albumin and/or lower CRP |
| US8337847B2 (en) | 2008-11-25 | 2012-12-25 | Alderbio Holdings Llc | Methods of treating anemia using anti-IL-6 antibodies |
| EP2504030A4 (en) | 2009-11-24 | 2013-06-26 | Alderbio Holdings Llc | IL-6 ANTAGONISTS FOR INCREASING ALBUMIN AND / OR REDUCING CRP |
| US9775921B2 (en) | 2009-11-24 | 2017-10-03 | Alderbio Holdings Llc | Subcutaneously administrable composition containing anti-IL-6 antibody |
| AU2011332817A1 (en) | 2010-11-23 | 2013-06-13 | Alder Biopharmaceuticals, Inc. | Anti-IL-6 antibodies for the treatment of anemia |
| WO2017184831A1 (en) | 2016-04-20 | 2017-10-26 | Regeneron Pharmaceuticals, Inc. | Compositions and methods for making antibodies based on use of an expression-enhancing locus |
| CN107526942B (zh) * | 2017-07-18 | 2021-04-20 | 中山大学 | 生命组学序列数据的反向检索方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6420526B1 (en) * | 1997-03-07 | 2002-07-16 | Human Genome Sciences, Inc. | 186 human secreted proteins |
| GB2331666A (en) * | 1997-11-20 | 1999-05-26 | Dsc Telecom Lp | Subscriber Terminal for a Wireless Telecommunications System |
| US6783961B1 (en) * | 1999-02-26 | 2004-08-31 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| CA2296792A1 (en) | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| EP1285084A1 (en) * | 2000-01-25 | 2003-02-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| JP2004530409A (ja) * | 2000-10-27 | 2004-10-07 | インサイト・ゲノミックス・インコーポレイテッド | 膜貫通タンパク質 |
| JP2004535759A (ja) * | 2000-11-16 | 2004-12-02 | インサイト・ゲノミックス・インコーポレイテッド | 免疫グロブリンスーパファミリタンパク質 |
| AU2003261142A1 (en) | 2002-07-12 | 2004-02-02 | Nuvelo,Inc. | Methods and materials relating to novel polypeptides and polynucleotides |
| CA2500521A1 (en) | 2002-10-02 | 2004-09-23 | Nuvelo, Inc. | Novel nucleic acids and polypeptides |
-
2002
- 2002-04-30 GB GBGB0209884.6A patent/GB0209884D0/en not_active Ceased
-
2003
- 2003-04-30 EP EP03722800A patent/EP1499640A2/en not_active Ceased
- 2003-04-30 WO PCT/GB2003/001851 patent/WO2003093316A2/en not_active Ceased
- 2003-04-30 BR BR0309638-6A patent/BR0309638A/pt not_active IP Right Cessation
- 2003-04-30 RS YU92704A patent/RS92704A/sr unknown
- 2003-04-30 CN CN038152525A patent/CN1665840A/zh active Pending
- 2003-04-30 KR KR10-2004-7017339A patent/KR20050008699A/ko not_active Ceased
- 2003-04-30 EA EA200401453A patent/EA007985B1/ru not_active IP Right Cessation
- 2003-04-30 JP JP2004501455A patent/JP2006502702A/ja active Pending
- 2003-04-30 AU AU2003229961A patent/AU2003229961B2/en not_active Ceased
- 2003-04-30 CA CA002483038A patent/CA2483038A1/en not_active Abandoned
- 2003-04-30 MX MXPA04010674A patent/MXPA04010674A/es not_active Application Discontinuation
- 2003-11-12 US US10/706,691 patent/US7622555B2/en not_active Expired - Fee Related
-
2004
- 2004-10-19 ZA ZA200408453A patent/ZA200408453B/en unknown
- 2004-10-21 IL IL16477704A patent/IL164777A0/xx unknown
- 2004-10-27 NO NO20044628A patent/NO20044628L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050008699A (ko) | 2005-01-21 |
| NO20044628L (no) | 2004-12-29 |
| EA007985B1 (ru) | 2007-02-27 |
| GB0209884D0 (en) | 2002-06-05 |
| BR0309638A (pt) | 2005-03-01 |
| US7622555B2 (en) | 2009-11-24 |
| IL164777A0 (en) | 2005-12-18 |
| EA200401453A1 (ru) | 2005-06-30 |
| ZA200408453B (en) | 2006-07-26 |
| JP2006502702A (ja) | 2006-01-26 |
| RS92704A (sr) | 2006-12-15 |
| AU2003229961B2 (en) | 2009-02-19 |
| CN1665840A (zh) | 2005-09-07 |
| AU2003229961A1 (en) | 2003-11-17 |
| EP1499640A2 (en) | 2005-01-26 |
| CA2483038A1 (en) | 2003-11-13 |
| WO2003093316A3 (en) | 2004-02-12 |
| US20040204352A1 (en) | 2004-10-14 |
| WO2003093316A2 (en) | 2003-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003229961B2 (en) | Immunoglobulin-domain containing cell surface recognition molecules | |
| IL182749A (en) | Vwfa and/or ant_ig domain containing proteins | |
| JP2005532034A (ja) | 分泌タンパク質 | |
| WO2008047111A1 (en) | Immunoglobulin domain-containing cell surface recognition molecules | |
| US7619065B2 (en) | Cystine-knot fold protein | |
| CA2510401A1 (en) | Defensin proteins | |
| AU2004289105B2 (en) | Cytokine antagonist molecules | |
| EP1802653B1 (en) | Mam domain containing protein | |
| US20100196349A1 (en) | Reeler domain containing protein | |
| AU2003241006B2 (en) | TNF-like secreted protein | |
| WO2008001045A1 (en) | Members of the glycoside hydrolase family 31 family of proteins | |
| AU2006335335A1 (en) | Cystine-knot fold cytokine | |
| WO2003100061A2 (en) | Three finger toxin fold proteins | |
| CA2436334A1 (en) | Adhesion molecules | |
| WO2004000882A2 (en) | Proteins | |
| US20080199435A1 (en) | IL-8 Like Protein | |
| WO2004009624A2 (en) | Three finger toxin fold protein | |
| WO2002050116A2 (en) | Adhesion molecule protein | |
| KR20060035601A (ko) | Ｔｎｆ-유사 분비 단백질 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |